FDA Import Refusal UPS-2620685-4/1/1 — Novartis Pharmaceuticals Canada Inc.

Novartis Pharmaceuticals Canada Inc. — FEI 3002260858

The FDA refused shipment UPS-2620685-4/1/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Sep 17, 2015. The refused product falls under Drugs and Biologics — CYCLOSPORINE (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Sep 17, 2015
Country
Canada
Product Category
Drugs and Biologics
Product Code
62GCA89 CYCLOSPORINE (ANTI-INFLAMMATORY)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.